Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subclinical hepatic encephalopathy impairs daily functioning

M Groeneweg1, J C Quero, I De Bruijn

  • 1Department of Hepatogastroenterology, Erasmus University Hospital, Rotterdam, The Netherlands.

Hepatology (Baltimore, Md.)
|July 10, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized trial comparing 5-year follow-up of first-line infliximab to conventional therapy in paediatric Crohn's disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Peppermint Oil and Sweets in Pediatric Irritable Bowel Syndrome and Functional Abdominal Pain: A Randomized Trial.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Individual Physiological Adaptations Enable Selected Bacterial Taxa To Prevail during Long-Term Incubations.

Applied and environmental microbiology·2019
Same author

IL-10 signaling prevents gluten-dependent intraepithelial CD4<sup>+</sup> cytotoxic T lymphocyte infiltration and epithelial damage in the small intestine.

Mucosal immunology·2018
Same author

Impact of Pseudomonas H6 surfactant on all external life cycle stages of the fish parasitic ciliate Ichthyophthirius multifiliis.

Journal of fish diseases·2018
Same author

Saddlebags: A software interface for submitting full-length HLA allele sequences to the EMBL-ENA nucleotide database.

HLA·2017
Same journal

Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD.

Hepatology (Baltimore, Md.)·2026
Same journal

A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease.

Hepatology (Baltimore, Md.)·2026
Same journal

AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Candidate evaluation.

Hepatology (Baltimore, Md.)·2026
Same journal

H4K12 lactylation drives TREM2 high macrophages differentiation in liver fibrosis.

Hepatology (Baltimore, Md.)·2026
Same journal

Good vibrations: Using VCTE to predict hepatic decompensation in MASLD.

Hepatology (Baltimore, Md.)·2026
Same journal

One size does not fit all: Global variability in noninvasive testing for MASLD.

Hepatology (Baltimore, Md.)·2026
See all related articles

Subclinical hepatic encephalopathy (SHE) significantly impairs daily functioning in cirrhosis patients. This study confirms SHE negatively impacts quality of life, supporting the need for treatment interventions.

Area of Science:

  • Hepatology
  • Neurology
  • Psychiatry

Background:

  • Subclinical hepatic encephalopathy (SHE) is presumed to affect daily functioning in cirrhosis patients, yet clinical relevance remains unquantified.
  • Previous research has not established the real-world impact of SHE on patients' lives.

Purpose of the Study:

  • To determine the prevalence of SHE in outpatients with cirrhosis.
  • To assess the influence of SHE on patients' daily functioning using the Sickness Impact Profile (SIP) questionnaire.

Main Methods:

  • 179 outpatients with cirrhosis were evaluated for SHE using psychometric tests (NCT-A, DGT) and EEG analysis.
  • SHE was diagnosed based on abnormal psychometric tests or EEG slowing.
  • Patient-reported daily functioning was measured using the SIP, with reproducibility assessed over 3 months.

Related Experiment Videos

Main Results:

  • The prevalence of SHE was determined in the study cohort.
  • Cirrhosis patients with SHE reported significantly greater impairment across all SIP scales (physical, psychosocial, total) compared to those without SHE.
  • Multivariate analysis confirmed SHE as an independent predictor of diminished daily functioning, even after accounting for disease severity and other factors.

Conclusions:

  • Subclinical hepatic encephalopathy is associated with significant impairment in daily functioning for patients with cirrhosis.
  • The findings underscore the clinical relevance of SHE and support the initiation of treatment strategies.
  • The SIP demonstrated high reproducibility, validating its use for assessing functional status in this population.